Inactive Instrument

Vycor Medical, Inc. Stock price Other OTC

Equities

VYCO

US92921M2035

Medical Equipment, Supplies & Distribution

Sales 2021 1.39M Sales 2022 1.22M Capitalization 2.93M
Net income 2021 - Net income 2022 - EV / Sales 2021 2.72 x
Net Debt 2021 777K Net Debt 2022 957K EV / Sales 2022 3.18 x
P/E ratio 2021
-3.82 x
P/E ratio 2022
-3.91 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 37.09%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 62 10-05-13
President 57 09-12-31
Chairman 65 09-12-31
Members of the board TitleAgeSince
Chief Executive Officer 62 10-05-13
Chairman 65 09-12-31
President 57 09-12-31
More insiders
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company operates through two segments: Vycor Medical and NovaVision. The Company's Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The Company designs, develops and markets neurological medical devices and therapies. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.
More about the company
  1. Stock
  2. Equities
  3. Stock Vycor Medical, Inc.
  4. Stock Vycor Medical, Inc. - Other OTC